본문 바로가기

보유기술

연구성과

강스템바이오텍은 세포치료제와 오가노이드 기반 플랫폼 기술을 중심으로 과학적 검증과 임상적 가능성을 동시에 갖춘 혁신 치료제를 개발하고 있습니다.

R&D Achievements

2015.01
DNA methyltransferase inhibition accelerates the immunomodulation and migration of human mesenchymal stem cells
Journal : Scientific Reports
2014.11
Excessive microglial activation aggravates olfactory dysfunction by impeding the survival of newborn neurons in the olfactory bulb of Niemann-Pick disease type C1 mice
Journal : BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
2014.10
A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging
Journal : PLoS One
2013.12
Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2
Journal : GASTROENTEROLOGY
2013.12
MicroRNA-141-3p plays a role in human mesenchymal stem cell aging by directly targeting ZMPSTE24
Journal : JOURNAL OF CELL SCIENCE

Company

About Us

인사말
비전 및 미션
연혁
오시는 길

Business

줄기세포 치료제

오가노이드

CDMO 사업

헬스&뷰티 사업

R&D

보유기술

Investors

공지사항

IR

PR